OGN
CompareOrganon & Company
Exchange: NYSESector: HealthcareIndustry: Drug Manufacturers - General
Organon & Company
Did you know?
Trading 31% above its estimated fair value of $7.77.
Current Price
$11.26
+30.93%GoodMoat Value
$7.77
31.0% overvaluedProfile
Valuation (TTM)
Market Cap$2.93B
P/E15.65
EV$9.65B
P/B3.89
Shares Out259.98M
P/Sales0.47
Revenue$6.22B
EV/EBITDA8.53
Organon & Company (OGN) Stock News
Macro Pulse mentions
- 7am ET · 8h ago
Sun Pharma agrees to acquire Organon for $11.75 billion — Organon jumped 14.8% in pre-market trading
- 5am ET · 10h ago
Sun Pharma agrees to acquire Organon for $11.75 billion — Organon jumped 14.8% in pre-market trading
- 4am ET · 11h ago
Organon agrees to $11.75B all-cash sale to Sun Pharma — OGN spikes nearly 17% in Robinhood 24-hour trading
- 2am ET · 13h ago
Organon agrees to $11.75B all-cash sale to Sun Pharma — OGN spikes nearly 17% in Robinhood 24-hour trading
OGN Stock News & Headlines
Latest stock news and headlines for Organon & Company (OGN). Stay informed on earnings reports, analyst upgrades and downgrades, market-moving events, and company announcements.
Current stock price: $11.26. Market cap: $2.93B. Sector: Healthcare. Industry: Drug Manufacturers - General. This page aggregates the latest news articles relevant to OGN from financial news sources, helping investors stay current on events that may impact Organon & Company's stock price.
News catalysts can drive significant short-term price movement. Earnings surprises, management changes, product launches, regulatory decisions, and analyst coverage changes all create opportunities and risks. Combine news monitoring with GoodMoat's fundamental analysis, quality scores, and valuation tools for a complete research workflow on Organon & Company (OGN).